Monday, November 25, 2024
HomeTagsInvenra

Invenra

Invenra’s INV724 Gets FDA Rare Pediatric & Orphan Drug Status for Neuroblastoma

Invenra Inc. is pleased to announce that its innovative bispecific antibody, INV724, developed for the treatment of neuroblastoma, has been awarded both Rare Pediatric...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics